Islam, R. Et Al. 2011. Primary colon cancer site as a predictor of bevacizumab effectiveness in metastatic colon cancer patients. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4 .

Islam, R., Chyou, P., Ege, H., Deedon, A., & Burmester, J. K., (2011). Primary colon cancer site as a predictor of bevacizumab effectiveness in metastatic colon cancer patients. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4.

Islam, R. Et Al. "Primary colon cancer site as a predictor of bevacizumab effectiveness in metastatic colon cancer patients," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4, 2011

Islam, R. Et Al. "Primary colon cancer site as a predictor of bevacizumab effectiveness in metastatic colon cancer patients." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4, 2011

Islam, R. Et Al. (2011) . "Primary colon cancer site as a predictor of bevacizumab effectiveness in metastatic colon cancer patients." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.4.

@article{article, author={R. Islam Et Al. }, title={Primary colon cancer site as a predictor of bevacizumab effectiveness in metastatic colon cancer patients}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}